Zealand Pharma
ISIN: DK0060257814 | Ticker: ZEAL | LEI: 549300ITBB1ULBL4CZ12
Country: Denmark
Zealand Pharma A/S was founded in 1998 and is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. We intend to be a leader in specialty medicines focusing on metabolic and gastrointestinal diseases and other rare disease areas with significant unmet medical needs. Zealand employs more than 300 people in Denmark and the US and has a portfolio of medicines and product candidates, including license collaborations with Boehringer Ingelheim.
Our pipeline focusing on gastrointestinal, metabolic and other specialty diseases where we believe that the present standard of care is inadequate and where we have the resources to advance our peptide-based product candidates into the later stages of clinical development, including registration and commercialization, while opportunistically considering partnership relationships that may arise.
1998
HeadquartersSydmarken 11, 2860 Søborg – Denmark
| Line item in (eur) | 01.01.2020 | 01.07.2020 | 01.10.2020 | 01.01.2021 | 01.04.2021 | 01.07.2021 | 01.10.2021 | 01.01.2022 | 01.04.2022 | 01.07.2022 | 01.10.2022 | 01.01.2023 | 01.04.2023 | 01.07.2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | N/A | N/A | N/A | 1,761,949,000.00 | N/A | 1,924,173,000.00 | 1,660,699,000.00 | 2,067,629,000.00 | 1,837,382,000.00 | 1,256,554,000.00 | 1,091,608,000.00 | 1,539,806,000.00 | N/A | 2,049,678,000.00 |
| Noncurrent Assets | N/A | N/A | N/A | 342,261,000.00 | N/A | 348,736,000.00 | 346,818,000.00 | 346,033,000.00 | 255,484,000.00 | 255,826,000.00 | 257,723,000.00 | 223,454,000.00 | N/A | 205,808,000.00 |
| Property Plant And Equipment | N/A | N/A | N/A | 85,040,000.00 | N/A | 85,393,000.00 | 83,308,000.00 | 86,455,000.00 | 64,036,000.00 | 64,868,000.00 | 62,655,000.00 | 50,528,000.00 | N/A | 48,819,000.00 |
| Intangible Assets Other Than Goodwill | N/A | N/A | N/A | 57,485,000.00 | N/A | 55,327,000.00 | 54,710,000.00 | 53,790,000.00 | 2,531,000.00 | 2,531,000.00 | 2,531,000.00 | 0.00 | N/A | N/A |
| Noncurrent Receivables | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 29,094,000.00 | N/A | N/A | N/A | 18,105,000.00 | N/A | 20,499,000.00 |
| Noncurrent Prepayments | N/A | N/A | N/A | 13,117,000.00 | N/A | 11,349,000.00 | 10,491,000.00 | 16,457,000.00 | 16,456,000.00 | 14,779,000.00 | 16,456,000.00 | N/A | N/A | N/A |
| Deferred Tax Assets | N/A | N/A | N/A | 8,370,000.00 | N/A | 5,077,000.00 | 8,344,000.00 | 13,525,000.00 | 6,738,000.00 | 0.00 | 0.00 | 2,017,000.00 | N/A | 1,983,000.00 |
| Current Tax Assets Noncurrent | N/A | N/A | N/A | 1,268,000.00 | N/A | 1,268,000.00 | 1,268,000.00 | 1,268,000.00 | 1,268,000.00 | 2,750,000.00 | 4,125,000.00 | 0.00 | N/A | 2,750,000.00 |
| Other Noncurrent Financial Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 | N/A | 6,779,000.00 | 6,921,000.00 | 6,901,000.00 | N/A | 7,131,000.00 |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | N/A | N/A | N/A | 32,333,000.00 | N/A | 33,427,000.00 | 34,682,000.00 | 26,907,000.00 | 29,736,000.00 | 31,786,000.00 | 33,857,000.00 | 30,943,000.00 | 16,194,000.00 | 16,194,000.00 |
| Longterm Deposits | N/A | N/A | N/A | 16,650,000.00 | N/A | 16,842,000.00 | 17,051,000.00 | 12,638,000.00 | 11,580,000.00 | 11,420,000.00 | 11,614,000.00 | N/A | N/A | N/A |
| Current Assets | N/A | N/A | N/A | 1,419,688,000.00 | N/A | 1,575,438,000.00 | 1,313,881,000.00 | 1,721,596,000.00 | 1,581,898,000.00 | 1,000,728,000.00 | 833,885,000.00 | 1,316,352,000.00 | N/A | 1,843,870,000.00 |
| Inventories | N/A | N/A | N/A | 65,040,000.00 | N/A | 106,216,000.00 | 116,359,000.00 | 118,436,000.00 | 3,760,000.00 | 818,000.00 | 0.00 | 1,286,000.00 | N/A | 12,823,000.00 |
| Trade And Other Current Receivables | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 153,453,000.00 | N/A | N/A | N/A | 115,622,000.00 | N/A | 117,077,000.00 |
| Current Trade Receivables | N/A | N/A | N/A | 46,484,000.00 | N/A | 99,296,000.00 | 80,489,000.00 | 73,025,000.00 | 71,083,000.00 | 45,032,000.00 | 33,560,000.00 | N/A | N/A | N/A |
| Current Prepaid Expenses | N/A | N/A | N/A | 35,156,000.00 | N/A | 39,731,000.00 | 30,469,000.00 | 64,626,000.00 | 63,817,000.00 | 52,742,000.00 | 41,475,000.00 | N/A | N/A | N/A |
| Other Current Receivables | N/A | N/A | N/A | 9,942,000.00 | N/A | 16,267,000.00 | 12,144,000.00 | 15,802,000.00 | 5,051,000.00 | 13,365,000.00 | 4,240,000.00 | N/A | N/A | N/A |
| Current Tax Assets Current | N/A | N/A | N/A | 5,500,000.00 | N/A | 30,995,000.00 | 25,442,000.00 | 21,562,000.00 | 16,448,000.00 | 24,327,000.00 | 24,724,000.00 | 21,599,000.00 | N/A | 21,596,000.00 |
| Cash and cash equivalents | 1,081,060,000.00 | 1,350,986,000.00 | 1,231,685,000.00 | 960,221,000.00 | 1,307,554,000.00 | 987,777,000.00 | 753,599,000.00 | 1,129,103,000.00 | 1,123,235,000.00 | 553,242,000.00 | 493,755,000.00 | 1,069,234,000.00 | 831,078,000.00 | 327,686,000.00 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 | 156,404,000.00 | N/A | N/A | N/A | N/A | N/A |
| Current Restricted Cash And Cash Equivalents | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 | N/A | N/A | 151,171,000.00 | N/A | N/A | N/A |
| Current Derivative Financial Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 | 142,100,000.00 | N/A | N/A | N/A | N/A | N/A |
| Current Investments | N/A | N/A | N/A | 297,345,000.00 | N/A | 295,155,000.00 | 295,379,000.00 | 299,042,000.00 | 0.00 | 311,202,000.00 | N/A | N/A | N/A | N/A |
| Equity And Liabilities | N/A | N/A | N/A | 1,761,949,000.00 | N/A | 1,924,173,000.00 | 1,660,699,000.00 | 2,067,629,000.00 | 1,837,382,000.00 | 1,256,554,000.00 | 1,091,608,000.00 | 1,539,806,000.00 | N/A | 2,049,678,000.00 |
| Equity | 1,242,673,000.00 | 1,799,922,000.00 | 1,590,003,000.00 | 1,229,311,000.00 | 1,662,746,000.00 | 1,386,736,000.00 | 1,185,746,000.00 | 927,803,000.00 | 709,697,000.00 | 504,947,000.00 | 366,440,000.00 | 815,911,000.00 | N/A | 1,727,435,000.00 |
| Issued Capital | N/A | N/A | N/A | 39,800,000.00 | N/A | 43,542,000.00 | 43,582,000.00 | 43,634,000.00 | 43,634,000.00 | 46,527,000.00 | 46,538,000.00 | 51,702,000.00 | N/A | 58,642,000.00 |
| Retained Earnings | N/A | N/A | N/A | -2,290,253,000.00 | N/A | -2,829,253,000.00 | -3,028,140,000.00 | 870,014,000.00 | -3,531,247,000.00 | 439,378,000.00 | 301,371,000.00 | 749,592,000.00 | N/A | 1,650,417,000.00 |
| Share Premium | N/A | N/A | N/A | 3,470,787,000.00 | N/A | 4,161,367,000.00 | 4,157,533,000.00 | 4,250,306,000.00 | 4,253,020,000.00 | N/A | N/A | N/A | N/A | N/A |
| Treasury Shares | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 71,890,000.00 | 71,890,000.00 | N/A | N/A | N/A | N/A | N/A |
| Liabilities | N/A | N/A | N/A | 532,638,000.00 | N/A | 537,437,000.00 | 474,953,000.00 | 1,139,826,000.00 | 1,127,685,000.00 | 751,607,000.00 | 725,168,000.00 | 723,895,000.00 | N/A | 322,243,000.00 |
| Noncurrent Liabilities | N/A | N/A | N/A | 177,378,000.00 | N/A | 161,840,000.00 | 164,257,000.00 | 805,509,000.00 | 797,520,000.00 | 490,024,000.00 | 499,241,000.00 | 528,404,000.00 | N/A | 121,132,000.00 |
| Noncurrent Payables | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 18,426,000.00 | N/A | N/A | N/A | 19,058,000.00 | N/A | 19,058,000.00 |
| Noncurrent Deferred Income Including Noncurrent Contract Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 14,551,000.00 | 2,113,000.00 | 0.00 | 0.00 | 0.00 | N/A | N/A |
| Other Noncurrent Liabilities | N/A | N/A | N/A | 16,744,000.00 | N/A | 18,227,000.00 | 18,227,000.00 | 18,426,000.00 | 18,427,000.00 | 18,426,000.00 | 18,426,000.00 | N/A | N/A | N/A |
| Longterm Borrowings | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 647,906,000.00 | 661,933,000.00 | 358,035,000.00 | 368,520,000.00 | 401,346,000.00 | 392,668,000.00 | 0.00 |
| Current Liabilities | N/A | N/A | N/A | 355,260,000.00 | N/A | 375,597,000.00 | 310,696,000.00 | 334,317,000.00 | 330,165,000.00 | 261,583,000.00 | 225,927,000.00 | 195,491,000.00 | N/A | 201,111,000.00 |
| Trade And Other Current Payables | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 266,387,000.00 | N/A | N/A | N/A | 180,762,000.00 | N/A | 186,324,000.00 |
| Trade And Other Current Payables To Trade Suppliers | N/A | N/A | N/A | 70,384,000.00 | N/A | 76,222,000.00 | 54,908,000.00 | 64,558,000.00 | 42,420,000.00 | 34,833,000.00 | 36,158,000.00 | N/A | N/A | N/A |
| Current Deferred Income Including Current Contract Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 53,033,000.00 | 54,514,000.00 | 31,238,000.00 | 16,100,000.00 | 0.00 | N/A | N/A |
| Current Tax Liabilities Current | N/A | N/A | N/A | 30,394,000.00 | N/A | 0.00 | 0.00 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Liabilities Included In Disposal Groups Classified As Held For Sale | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 | 8,932,000.00 | N/A | N/A | N/A | N/A | N/A |
| Other Current Liabilities | N/A | N/A | N/A | 150,555,000.00 | N/A | 185,945,000.00 | 151,550,000.00 | 173,134,000.00 | 135,804,000.00 | 149,717,000.00 | 151,605,000.00 | N/A | N/A | N/A |
| Line item in (eur) | 01.01.2020/ 01.07.2020 |
01.01.2020/ 01.10.2020 |
01.01.2020/ 01.01.2021 |
01.04.2020/ 01.07.2020 |
01.07.2020/ 01.10.2020 |
01.01.2021/ 01.04.2021 |
01.01.2021/ 01.07.2021 |
01.01.2021/ 01.10.2021 |
01.01.2021/ 01.01.2022 |
01.04.2021/ 01.07.2021 |
01.06.2021/ 01.10.2021 |
01.07.2021/ 01.10.2021 |
01.01.2022/ 01.04.2022 |
01.01.2022/ 01.07.2022 |
01.01.2022/ 01.10.2022 |
01.01.2022/ 01.01.2023 |
01.04.2022/ 01.07.2022 |
01.06.2022/ 01.10.2022 |
01.01.2023/ 01.04.2023 |
01.01.2023/ 01.07.2023 |
01.04.2023/ 01.07.2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 233,432,000.00 | 289,958,000.00 | 192,001,000.00 | 221,016,000.00 | 56,526,000.00 | 5,704,000.00 | 42,251,000.00 | 95,114,000.00 | 108,546,000.00 | 36,547,000.00 | 54,188,000.00 | 106,407,000.00 | 15,077,000.00 | 43,451,000.00 | 80,061,000.00 | 103,986,000.00 | 28,374,000.00 | 43,714,000.00 | N/A | 24,036,000.00 | 10,407,000.00 |
| Other Income | 858,000.00 | 37,724,000.00 | N/A | 751,000.00 | 36,866,000.00 | 254,000.00 | 488,000.00 | 614,000.00 | 759,000.00 | 234,000.00 | 126,000.00 | 73,000.00 | 112,000.00 | 1,849,000.00 | 1,854,000.00 | N/A | 1,738,000.00 | 27,000.00 | N/A | N/A | N/A |
| Profit Loss From Operating Activities | -230,912,000.00 | -449,120,000.00 | -626,235,000.00 | -53,710,000.00 | -218,207,000.00 | -261,133,000.00 | -551,886,000.00 | -568,662,000.00 | -784,317,000.00 | -290,753,000.00 | -158,479,000.00 | -211,803,000.00 | -301,997,000.00 | -539,197,000.00 | -596,184,000.00 | -837,153,000.00 | -237,200,000.00 | -162,076,000.00 | N/A | -364,039,000.00 | -195,365,000.00 |
| Finance Income | 904,000.00 | 900,000.00 | 2,022,000.00 | 2,180,000.00 | 3,799,000.00 | 22,589,000.00 | 11,511,000.00 | 29,427,000.00 | 41,211,000.00 | 0.00 | 18,548,000.00 | 18,548,000.00 | 153,505,000.00 | 111,891,000.00 | 130,776,000.00 | 133,270,000.00 | -41,614,000.00 | 18,885,000.00 | N/A | 19,197,000.00 | 11,760,000.00 |
| Finance Costs | 9,907,000.00 | 19,649,000.00 | 49,314,000.00 | 8,026,000.00 | 13,545,000.00 | 2,750,000.00 | 6,061,000.00 | 7,907,000.00 | 15,781,000.00 | 14,389,000.00 | 2,477,000.00 | 2,477,000.00 | 20,472,000.00 | 173,730,000.00 | 184,197,000.00 | 268,158,000.00 | 153,259,000.00 | 10,467,000.00 | N/A | 171,531,000.00 | 137,445,000.00 |
| Profit Loss Before Tax | -239,915,000.00 | -467,869,000.00 | -673,527,000.00 | -59,556,000.00 | -227,953,000.00 | -241,294,000.00 | -546,436,000.00 | -547,142,000.00 | -758,887,000.00 | -305,142,000.00 | -142,408,000.00 | -195,732,000.00 | -168,964,000.00 | -601,036,000.00 | -649,605,000.00 | -972,041,000.00 | -432,073,000.00 | -153,658,000.00 | N/A | -516,373,000.00 | -321,050,000.00 |
| Income Tax Expense Continuing Operations | -2,306,000.00 | -1,686,000.00 | -4,814,000.00 | -1,375,000.00 | 621,000.00 | 904,000.00 | -6,832,000.00 | -2,944,000.00 | -3,949,000.00 | -7,737,000.00 | -998,000.00 | 3,155,000.00 | 12,076,000.00 | 12,435,000.00 | -5,056,000.00 | -6,431,000.00 | 358,000.00 | -1,776,000.00 | N/A | -3,239,000.00 | -1,548,000.00 |
| Profit Loss From Continuing Operations | N/A | N/A | -668,713,000.00 | N/A | N/A | -242,198,000.00 | -539,604,000.00 | -544,198,000.00 | -754,938,000.00 | -297,405,000.00 | -141,410,000.00 | N/A | -181,040,000.00 | -613,471,000.00 | -644,549,000.00 | -965,610,000.00 | -432,431,000.00 | -151,882,000.00 | N/A | -513,134,000.00 | -319,502,000.00 |
| Profit Loss From Discontinued Operations | N/A | N/A | -178,016,000.00 | N/A | N/A | 14,000.00 | 604,000.00 | -193,689,000.00 | -263,211,000.00 | 590,000.00 | -57,477,000.00 | N/A | -41,805,000.00 | -97,874,000.00 | -215,138,000.00 | -236,525,000.00 | -56,069,000.00 | 3,540,000.00 | N/A | 0.00 | 0.00 |
| Profit (loss) | -237,609,000.00 | -466,183,000.00 | -846,729,000.00 | -58,181,000.00 | -228,574,000.00 | -242,184,000.00 | -539,000,000.00 | -737,887,000.00 | -1,018,149,000.00 | -296,815,000.00 | -198,887,000.00 | -198,887,000.00 | -222,845,000.00 | -711,345,000.00 | -859,687,000.00 | -1,202,135,000.00 | -488,500,000.00 | -148,342,000.00 | -193,632,000.00 | -513,134,000.00 | -319,502,000.00 |
| Line item in (eur) | 01.01.2020 | 01.07.2020 | 01.10.2020 | 01.01.2021 | 01.04.2021 | 01.07.2021 | 01.10.2021 | 01.01.2022 | 01.04.2022 | 01.07.2022 | 01.10.2022 | 01.01.2023 | 01.04.2023 | 01.07.2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) | N/A | -58,181,000.00 | -228,574,000.00 | -846,729,000.00 | -242,184,000.00 | -296,815,000.00 | -198,887,000.00 | -1,018,149,000.00 | -222,845,000.00 | -488,500,000.00 | -148,342,000.00 | -1,202,135,000.00 | -193,632,000.00 | -319,502,000.00 |
| Other Adjustments For Noncash Items | N/A | 39,337,000.00 | 87,607,000.00 | 63,862,000.00 | -49,586,000.00 | -92,581,000.00 | 33,015,000.00 | 17,430,000.00 | -79,934,000.00 | 143,029,000.00 | 192,960,000.00 | 269,622,000.00 | N/A | 180,147,000.00 |
| Interest Paid Classified As Operating Activities | N/A | 3,406,000.00 | 5,862,000.00 | 4,562,000.00 | 962,000.00 | 3,190,000.00 | 5,347,000.00 | 3,296,000.00 | 11,642,000.00 | 17,713,000.00 | 20,004,000.00 | 34,414,000.00 | N/A | 20,341,000.00 |
| Interest Received Classified As Operating Activities | N/A | 897,000.00 | 901,000.00 | 895,000.00 | N/A | 0.00 | 0.00 | 0.00 | N/A | 1,226,000.00 | 3,045,000.00 | 5,178,000.00 | N/A | 15,665,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | N/A | 0.00 | 0.00 | 0.00 | 0.00 | 44,740,000.00 | 46,971,000.00 | 41,631,000.00 | -183,000.00 | 700,000.00 | -1,436,000.00 | -9,277,000.00 | N/A | -236,000.00 |
| Cash Flows From Used In Operating Activities | N/A | -313,518,000.00 | -411,628,000.00 | -688,716,000.00 | -368,132,000.00 | -695,703,000.00 | -904,257,000.00 | -1,211,971,000.00 | -317,011,000.00 | -543,920,000.00 | -669,927,000.00 | -942,209,000.00 | N/A | -372,480,000.00 |
| Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | N/A | N/A | 0.00 | N/A | 0.00 | 0.00 | 0.00 | N/A | 104,852,000.00 | 104,852,000.00 | 106,386,000.00 | N/A | 0.00 |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | 167,725,000.00 | 167,725,000.00 | 167,791,000.00 | N/A | 0.00 | 0.00 | 0.00 | N/A | N/A | N/A | 0.00 | N/A | N/A |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 14,392,000.00 | 29,491,000.00 | 25,044,000.00 | 4,480,000.00 | 3,858,000.00 | 5,854,000.00 | 22,133,000.00 | 3,738,000.00 | 4,759,000.00 | 5,083,000.00 | 11,710,000.00 | N/A | 3,686,000.00 |
| Cash Flows From Used In Investing Activities | N/A | -186,428,000.00 | -200,799,000.00 | -196,807,000.00 | -4,828,000.00 | -4,050,000.00 | -6,255,000.00 | -18,121,000.00 | 294,248,000.00 | 101,399,000.00 | 178,566,000.00 | 281,259,000.00 | N/A | -1,260,893,000.00 |
| Proceeds From Issuing Shares | N/A | 794,929,000.00 | 794,929,000.00 | 791,503,000.00 | 748,974,000.00 | 748,975,000.00 | 748,975,000.00 | 748,975,000.00 | 0.00 | 274,776,000.00 | 274,775,000.00 | 1,060,825,000.00 | N/A | 1,500,000,000.00 |
| Payments To Acquire Or Redeem Entitys Shares | N/A | N/A | 0.00 | 0.00 | N/A | N/A | 28,595,000.00 | 28,590,000.00 | N/A | 0.00 | 0.00 | 0.00 | N/A | 41,600,000.00 |
| Proceeds From Borrowings Classified As Financing Activities | N/A | N/A | N/A | 0.00 | N/A | N/A | 0.00 | 647,906,000.00 | N/A | N/A | 0.00 | 0.00 | N/A | N/A |
| Repayments Of Borrowings Classified As Financing Activities | N/A | N/A | N/A | 0.00 | N/A | 0.00 | 0.00 | 0.00 | N/A | 417,340,000.00 | 436,088,000.00 | 436,088,000.00 | N/A | 525,764,000.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | N/A | 15,281,000.00 | 10,246,000.00 | 29,219,000.00 | 2,896,000.00 | 2,883,000.00 | 8,195,000.00 | 14,715,000.00 | 3,461,000.00 | 4,225,000.00 | 10,246,000.00 | 13,719,000.00 | N/A | 6,351,000.00 |
| Cash Flows From Used In Financing Activities | N/A | 770,249,000.00 | 780,826,000.00 | 760,941,000.00 | 703,536,000.00 | 715,929,000.00 | 686,440,000.00 | 1,332,751,000.00 | -3,461,000.00 | -154,942,000.00 | -178,535,000.00 | 587,398,000.00 | N/A | 897,384,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | 270,303,000.00 | 168,399,000.00 | -124,582,000.00 | 330,576,000.00 | 16,176,000.00 | -224,072,000.00 | 102,659,000.00 | -26,224,000.00 | -597,463,000.00 | -669,896,000.00 | -73,552,000.00 | -231,365,000.00 | -735,989,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | -376,000.00 | -17,775,000.00 | 3,743,000.00 | 16,757,000.00 | 11,380,000.00 | 17,450,000.00 | 66,223,000.00 | 20,356,000.00 | 21,602,000.00 | 34,548,000.00 | 13,683,000.00 | N/A | -5,559,000.00 |
| Cash and cash equivalents | 1,081,060,000.00 | 1,350,986,000.00 | 1,231,685,000.00 | 960,221,000.00 | 1,307,554,000.00 | 987,777,000.00 | 753,599,000.00 | 1,129,103,000.00 | 1,123,235,000.00 | 553,242,000.00 | 493,755,000.00 | 1,069,234,000.00 | 831,078,000.00 | 327,686,000.00 |
Please note that some sums might not add up.
DK0060257814
LEI549300ITBB1ULBL4CZ12
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.